Preventive Healthcare Technologies And Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509244898

Publication Date:

September 20, 2024

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Increasing prevalence of chronic diseases and growing demand for the preventive measures are expected to fuel the preventive healthcare technologies and services market growth.
The global market for Preventive Healthcare Technologies And Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Preventive Healthcare Technologies And Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Preventive Healthcare Technologies And Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Preventive Healthcare Technologies And Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Preventive Healthcare Technologies And Services include 23andMe, MyHeritage, Myriad Genetics, Quest Diagnostics, Medtronic, Abbott, Merck, GlaxoSmithKline and Sanofi, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Preventive Healthcare Technologies And Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Preventive Healthcare Technologies And Services by region & country, by Type, and by Application.
The Preventive Healthcare Technologies And Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventive Healthcare Technologies And Services.
麻豆原创 Segmentation
By Company
23andMe
MyHeritage
Myriad Genetics
Quest Diagnostics
Medtronic
Abbott
Merck
GlaxoSmithKline
Sanofi
Pfizer
China National Biotec
Segment by Type:
Gene Testing & Screening
Vaccines
Segment by Application
Adults
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Preventive Healthcare Technologies And Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Preventive Healthcare Technologies And Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Preventive Healthcare Technologies And Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Preventive Healthcare Technologies And Services Product Introduction
1.2 Global Preventive Healthcare Technologies And Services 麻豆原创 Size Forecast
1.3 Preventive Healthcare Technologies And Services 麻豆原创 Trends & Drivers
1.3.1 Preventive Healthcare Technologies And Services Industry Trends
1.3.2 Preventive Healthcare Technologies And Services 麻豆原创 Drivers & Opportunity
1.3.3 Preventive Healthcare Technologies And Services 麻豆原创 Challenges
1.3.4 Preventive Healthcare Technologies And Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Preventive Healthcare Technologies And Services Players Revenue Ranking (2023)
2.2 Global Preventive Healthcare Technologies And Services Revenue by Company (2019-2024)
2.3 Key Companies Preventive Healthcare Technologies And Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Preventive Healthcare Technologies And Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Preventive Healthcare Technologies And Services
2.6 Preventive Healthcare Technologies And Services 麻豆原创 Competitive Analysis
2.6.1 Preventive Healthcare Technologies And Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Preventive Healthcare Technologies And Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventive Healthcare Technologies And Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Gene Testing & Screening
3.1.2 Vaccines
3.2 Global Preventive Healthcare Technologies And Services Sales Value by Type
3.2.1 Global Preventive Healthcare Technologies And Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Preventive Healthcare Technologies And Services Sales Value, by Type (2019-2030)
3.2.3 Global Preventive Healthcare Technologies And Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Preventive Healthcare Technologies And Services Sales Value by Application
4.2.1 Global Preventive Healthcare Technologies And Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Preventive Healthcare Technologies And Services Sales Value, by Application (2019-2030)
4.2.3 Global Preventive Healthcare Technologies And Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Preventive Healthcare Technologies And Services Sales Value by Region
5.1.1 Global Preventive Healthcare Technologies And Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Preventive Healthcare Technologies And Services Sales Value by Region (2019-2024)
5.1.3 Global Preventive Healthcare Technologies And Services Sales Value by Region (2025-2030)
5.1.4 Global Preventive Healthcare Technologies And Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Preventive Healthcare Technologies And Services Sales Value, 2019-2030
5.2.2 North America Preventive Healthcare Technologies And Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Preventive Healthcare Technologies And Services Sales Value, 2019-2030
5.3.2 Europe Preventive Healthcare Technologies And Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Preventive Healthcare Technologies And Services Sales Value, 2019-2030
5.4.2 Asia Pacific Preventive Healthcare Technologies And Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Preventive Healthcare Technologies And Services Sales Value, 2019-2030
5.5.2 South America Preventive Healthcare Technologies And Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Preventive Healthcare Technologies And Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Preventive Healthcare Technologies And Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Preventive Healthcare Technologies And Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Preventive Healthcare Technologies And Services Sales Value
6.3 United States
6.3.1 United States Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.3.2 United States Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.4.2 Europe Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.5.2 China Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.6.2 Japan Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.7.2 South Korea Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.8.2 Southeast Asia Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Preventive Healthcare Technologies And Services Sales Value, 2019-2030
6.9.2 India Preventive Healthcare Technologies And Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Preventive Healthcare Technologies And Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 23andMe
7.1.1 23andMe Profile
7.1.2 23andMe Main Business
7.1.3 23andMe Preventive Healthcare Technologies And Services Products, Services and Solutions
7.1.4 23andMe Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.1.5 23andMe Recent Developments
7.2 MyHeritage
7.2.1 MyHeritage Profile
7.2.2 MyHeritage Main Business
7.2.3 MyHeritage Preventive Healthcare Technologies And Services Products, Services and Solutions
7.2.4 MyHeritage Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.2.5 MyHeritage Recent Developments
7.3 Myriad Genetics
7.3.1 Myriad Genetics Profile
7.3.2 Myriad Genetics Main Business
7.3.3 Myriad Genetics Preventive Healthcare Technologies And Services Products, Services and Solutions
7.3.4 Myriad Genetics Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.3.5 Quest Diagnostics Recent Developments
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Profile
7.4.2 Quest Diagnostics Main Business
7.4.3 Quest Diagnostics Preventive Healthcare Technologies And Services Products, Services and Solutions
7.4.4 Quest Diagnostics Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.4.5 Quest Diagnostics Recent Developments
7.5 Medtronic
7.5.1 Medtronic Profile
7.5.2 Medtronic Main Business
7.5.3 Medtronic Preventive Healthcare Technologies And Services Products, Services and Solutions
7.5.4 Medtronic Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.5.5 Medtronic Recent Developments
7.6 Abbott
7.6.1 Abbott Profile
7.6.2 Abbott Main Business
7.6.3 Abbott Preventive Healthcare Technologies And Services Products, Services and Solutions
7.6.4 Abbott Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.6.5 Abbott Recent Developments
7.7 Merck
7.7.1 Merck Profile
7.7.2 Merck Main Business
7.7.3 Merck Preventive Healthcare Technologies And Services Products, Services and Solutions
7.7.4 Merck Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.7.5 Merck Recent Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Profile
7.8.2 GlaxoSmithKline Main Business
7.8.3 GlaxoSmithKline Preventive Healthcare Technologies And Services Products, Services and Solutions
7.8.4 GlaxoSmithKline Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline Recent Developments
7.9 Sanofi
7.9.1 Sanofi Profile
7.9.2 Sanofi Main Business
7.9.3 Sanofi Preventive Healthcare Technologies And Services Products, Services and Solutions
7.9.4 Sanofi Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.9.5 Sanofi Recent Developments
7.10 Pfizer
7.10.1 Pfizer Profile
7.10.2 Pfizer Main Business
7.10.3 Pfizer Preventive Healthcare Technologies And Services Products, Services and Solutions
7.10.4 Pfizer Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.10.5 Pfizer Recent Developments
7.11 China National Biotec
7.11.1 China National Biotec Profile
7.11.2 China National Biotec Main Business
7.11.3 China National Biotec Preventive Healthcare Technologies And Services Products, Services and Solutions
7.11.4 China National Biotec Preventive Healthcare Technologies And Services Revenue (US$ Million) & (2019-2024)
7.11.5 China National Biotec Recent Developments
8 Industry Chain Analysis
8.1 Preventive Healthcare Technologies And Services Industrial Chain
8.2 Preventive Healthcare Technologies And Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Preventive Healthcare Technologies And Services Sales Model
8.5.2 Sales Channel
8.5.3 Preventive Healthcare Technologies And Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

23andMe
MyHeritage
Myriad Genetics
Quest Diagnostics
Medtronic
Abbott
Merck
GlaxoSmithKline
Sanofi
Pfizer
China National Biotec

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.